Flu Season: New data from the NHS shows rapid rise in flu cases across the UK, whilst across the world, china continues its battle against human metapneumovirus virus.
In February, 16% of the world's population pre-ordered 70% of available COVID vaccines - now, researchers at Colombia University reveal that some poorer countries won't be able to vaccinate their population until 2023.
Pfizer CEO Albert Bourla suggested that fully vaccinated people would need their third vaccine dose, maybe 12 months after they got their second - the EU is currently in talks to secure a further 1.8 billion doses.
According to a Kaiser Permanente study, the rate of recommended vaccine doses administered to children has dramatically decreased since the outbreak of COVID-19.
An international study examined hospitalised COVID patients across 11 countries - finding that obese patients are 73% more likely to need invasive respiratory support.
Yesterday (14 April) EU President Ursula von der Leyen announced that the Commission would create a third contract with Pfizer, for 1.8 billion doses between 2021 to 2023.
Scientists from the University of Manchester have discovered an alteration in the immune system of COVID-19 patients 6 months after hospitalisation, which could be linked to poorer health outcomes.
Researchers in the UK started a clinical trial on mixing vaccines in February - today (14 April) a new study will look into mixing Moderna and Novavax doses.
US authorities paused the use of the Johnson & Johnson single dose vaccine as they look into six cases of blood clots that developed in women aged between 18 and 48.
Uninfected people lived with one infected individual as part of the study - the COVID antibody drug gave them 72% protection against catching the virus themselves.
Here, we learn how world leading supplier Bioquell devised a PRP for a Biopharmaceutical Production Facility ensuring high-level bio-decontamination in the event of contamination.
